Tewodros Eguale
McGill University
H-index: 31
North America-Canada
Top articles of Tewodros Eguale
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
The cost-effectiveness of metformin in the US diabetes prevention program trial: Simple interpretations need not apply | Brian E Rittenhouse Sultan Alolayan Tewodros Eguale Alissa R Segal Joanne Doucette | 2024/1/1 | |
PCR166 PRO Reporting and Methodological Rigor in NSCLC RCTs, a Cause for Concern | R Kandikatla A Fathima VK Yakkala U Patel I Yunusa | 2023/6/1 | |
EPH146 Signal Detection Using Data from FDA Adverse Event Reporting System (FAERS): Infections in Biologics Vs Biosimilars | Value in Health | U Patel T Eguale B Rittenhouse I Yunusa R Kandikatla | 2023/6/1 |
EE466 Correcting a Cost-Effectiveness Analysis (CEA) with Suggestions on Ways of Avoiding Misinterpretations and Calculating Errors Associated with Them: The Singapore Diabetes … | Value in Health | JL Paredes B Rittenhouse T Eguale A Segal J Doucette | 2023/6/1 |
Assessing the Assessment—Developing and Deploying a Novel Tool for Evaluating Clinical Notes’ Diagnostic Assessment Quality | Journal of General Internal Medicine | Mirica Maria Khazen Maram Hussein Sarib Ramos Jason Tewodros Eguale | 2023/7 |
PCR218 Evaluating the Adherence of Reporting Patient Reported Outcomes to the Consort PRO Extension, CONSORT-Outcomes Extension and ISOQOL Standards Among Aggressive Large B … | AF Mohamed R Kandikatla A Thirugnanam NM Patel U Patel | 2023/6/1 | |
EE321 A Re-Examination of a Cost-Minimization Analysis in Multiple Sclerosis: Assessing Biases from the Inaccurate Assumption of Equal Effectiveness Using Probabilistic … | Value in Health | C Pretorius B Rittenhouse T Eguale JD Kallich | 2022/7/1 |
EPH9 Overall Mortality Among Patients with Hemophilia: A Systematic Review and Meta-Analysis | I Sultan SS Syed A Fathima H Farag I Yunusa | 2022/7/1 | |
EE84 A Reexamination of Drug Costs for Cetuximab and Panitumimab in Metastatic Colorectal Cancer: Assessing the Influence of Drug Vial Splitting | Value in Health | S Puskuru B Rittenhouse JD Kallich T Eguale | 2022/7/1 |
RWD111 Analysis on Prescribing Practices of Primary Care Providers Using Real World Data | Value in Health | SS Syed T Eguale M Mirica G Schiff | 2022/7/1 |
Comparison of amitriptyline and us food and drug administration–approved treatments for fibromyalgia: a systematic review and network meta-analysis | Hussein M Farag Ismaeel Yunusa Hardik Goswami Ihtisham Sultan Joanne A Doucette | 2022/5/2 | |
EPH52 Cause-Specific Mortality Among Patients with Hemophilia: A Systematic Review and Meta-Analysis | I Sultan SS Syed A Fathima H Farag I Yunusa | 2022/7/1 | |
DOES EARLY VASOPRESSOR USE IN SEPSIS RESULT IN BETTER OUTCOMES? A SYSTEMATIC REVIEW AND META-ANALYSIS | Ethar Makhseed Mohammad Ghanbar Tewodros Eguale | 2021/10/1 | |
Personal Formularies of Primary Care Physicians Across 4 Health Care Systems (vol 4, e2117038, 2021) | JAMA network open | William Galanter Tewodros Eguale Walid Gellad Bruce Lambert Maria Mirica | 2021/7/1 |
Extended duration venous thromboembolism prophylaxis with betrixaban for patients re-admitted with venous thromboembolism | Annals of Internal Medicine | Michael P Carson Yen-Hong Kuo | 2010/11/16 |
Detection of adverse drug events in e-prescribing and administrative health data: a validation study | BMC Health Services Research | Bettina Habib Robyn Tamblyn Nadyne Girard Tewodros Eguale Allen Huang | 2021/4/23 |
Comparative value of cholinesterase inhibitors and memantine in persons with moderate-to-severe Alzheimer’s disease in the United States: a cost-effectiveness analysis | Journal of Alzheimer's disease reports | Ismaeel Yunusa Saud Alsahali Amey Rane Tewodros Eguale | 2021/9/6 |
Efficacy and Safety of Direct Oral Anticoagulants versus Warfarin in Patients with Venous Thromboembolism or Nonvalvular Atrial Fibrillation and Chronic Kidney Disease a … | M Mhanna A Beran A Al-Abdouh O Srour W Abdulsattar | 2021/10/1 | |
PND47 COST-EFFECTIVENESS ANALYSIS OF PHARMACOLOGICAL TREATMENTS OF MODERATE-TO-SEVERE ALZHEIMER'S DISEASE | Value in Health | I Yunusa A Rane I Sultan T Eguale | 2020/5/1 |
PDB22 THE DIABETES PREVENTION PROGRAM (DPP) QUALITY OF WELL BEING (QWB) AND SF-6D UTILITY MEASURES AND MISSING DATA CONSIDERATIONS: AVAILABLE CASE ANALYSIS (ACA) VS. MANSKI … | Value in Health | P Gebrehiwet T Eguale A Segal B Rittenhouse | 2020/5/1 |
